Cargando…

Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma

Recently, increasing attention has been paid to the role of Squalene epoxidase (SQLE) in several types of cancers. However, its functional role in tumor progression of head and neck squamous cell carcinoma (HNSCC) is still unclear. We performed bioinformatic analyses and relative experiments to asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Yang, Tao, Wang, Qihong, Li, Yuedan, Wu, Haiyan, Zhang, Mei, Qi, Hong, Zhang, Hongxin, Li, Jinfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254471/ https://www.ncbi.nlm.nih.gov/pubmed/35813482 http://dx.doi.org/10.7150/ijbs.68216

Ejemplares similares

High SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2021)

The interaction between polyphyllin I and SQLE protein induces hepatotoxicity through SREBP-2/HMGCR/SQLE/LSS pathway
por: Li, Zhiqi, et al.
Publicado: (2023)

SQLE facilitates the pancreatic cancer progression via the lncRNA‐TTN‐AS1/miR‐133b/SQLE axis
por: Wang, Shuhui, et al.
Publicado: (2022)

MYC Enhances Cholesterol Biosynthesis and Supports Cell Proliferation Through SQLE
por: Yang, Fan, et al.
Publicado: (2021)

HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma
por: Zhao, Hongyu, et al.
Publicado: (2022)

Corrigendum: MYC Enhances Cholesterol Biosynthesis and Supports Cell Proliferation Through SQLE
por: Yang, Fan, et al.
Publicado: (2021)

Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell Carcinoma
por: Parikh, Anuraag S., et al.
Publicado: (2023)

CD8(+) T-cell exhaustion in the tumor microenvironment of head and neck squamous cell carcinoma determines poor prognosis
por: Zhang, Yijian, et al.
Publicado: (2022)

Downregulated ferroptosis‐related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma
por: Yao, Lei, et al.
Publicado: (2022)

Upregulated SLC22A3 has a potential for improving survival of patients with head and neck squamous cell carcinoma receiving cisplatin treatment
por: Hsu, Cheng-Ming, et al.
Publicado: (2017)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer
por: Xu, Zhenzhou, et al.
Publicado: (2021)

A risk prediction model mediated by genes of APOD/APOC1/SQLE associates with prognosis in cervical cancer
por: Zhang, Ya, et al.
Publicado: (2022)

Upregulation of ASAP3 contributes to colorectal carcinogenesis and indicates poor survival outcome
por: Tian, Haiying, et al.
Publicado: (2017)

KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck
por: Huang, Donghai, et al.
Publicado: (2018)

High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent‐free survival in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Fascin upregulation in primary head and neck squamous cell carcinoma is associated with lymphatic metastasis
por: PAPASPYROU, KONSTANTINOS, et al.
Publicado: (2014)

Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
por: Li, Wenya, et al.
Publicado: (2023)

Overexpression of TRMT12 may independently predict poor overall survival in patients with head and neck squamous cell carcinoma
por: Wang, Kai, et al.
Publicado: (2019)

Upregulation of KHDC1L promotes the proliferation and inhibits apoptosis in head and neck squamous cell carcinoma
por: Zhang, Qi, et al.
Publicado: (2023)

Influence of Body Mass Index on Survival and Prognosis in Squamous Cell Carcinoma of Head and Neck
por: Li, Peng, et al.
Publicado: (2020)

Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma
por: Guo, Erliang, et al.
Publicado: (2021)

Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients
por: Ju, Jun, et al.
Publicado: (2016)

Multifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma
por: Porcheri, Cristina, et al.
Publicado: (2019)

Socioeconomic factors and survival in patients with non‐metastatic head and neck squamous cell carcinoma
por: Xu, Cheng, et al.
Publicado: (2017)

Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
por: Ma, Hailong, et al.
Publicado: (2018)

FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma
por: Liao, Qingyun, et al.
Publicado: (2023)

Clinical study of poorly differentiated head and neck squamous cell carcinoma: a prospective cohort study in China
por: Ding, Shuo, et al.
Publicado: (2022)

Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer
por: Tang, Wenqing, et al.
Publicado: (2021)

Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma
por: Hu, Zele, et al.
Publicado: (2020)

Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma
por: Hu, Chunmei, et al.
Publicado: (2022)

Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis
por: Bai, Xiuhui, et al.
Publicado: (2021)

Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma
por: Li, Guo, et al.
Publicado: (2015)

Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas
por: Huang, Yongsheng, et al.
Publicado: (2022)

Overexpression of TWIST2 correlates with poor prognosis in Head and Neck Squamous Cell Carcinomas
por: Gasparotto, Daniela, et al.
Publicado: (2011)

Head and Neck Squamous Cell Carcinoma in Western Uganda: Disease of Uncertainty and Poor Prognosis
por: Nabukenya, Jamilah, et al.
Publicado: (2018)

Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma
por: Ahmadi, Mohsen, et al.
Publicado: (2021)

LAT1 is associated with poor prognosis and radioresistance in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2023)

High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma
por: Li, Bo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eu4l1igfthmbm7bv1touhl6ga6